Literature DB >> 10992485

Peptide mimic of phosphorylcholine, a dominant epitope found on Streptococcus pneumoniae.

S L Harris1, M K Park, M H Nahm, B Diamond.   

Abstract

Even in the age of antibiotics, Streptococcus pneumoniae causes significant morbidity, especially in the young, the elderly, and the immunocompromised. While a carbohydrate-based vaccine exists, it is poorly immunogenic in the at-risk populations. In mice, antibodies directed against phosphorylcholine (PC), an epitope present on the cell wall C polysaccharide of all pneumococcal serotypes, protect against infection. However, PC itself is a poor vaccine candidate. We report here peptide mimics of PC based on the anti-idiotypic interaction of T15 anti-PC antibodies. T15 antibodies, the dominant and protective idiotype induced in mice by PC immunization, self-associate via a 24-amino-acid region in the PC binding site (ASRNKANDYTTEYSASVKGRFIVS; peptide 1). Peptide 1 has been shown to bind in the PC binding site. We demonstrated that amino acid sequences derived from peptide 1 starting at amino acid 9, 11, or 13 inhibit PC binding. Therefore, we immunized mice with bovine serum albumin (BSA) conjugates of peptide 1 or either of two selected 12-mers. The 12-mer peptides were not immunogenic. Mice immunized with peptide 1-BSA developed an anti-PC response consisting mainly immunoglobulin G1 and expressed the T15 heavy chain. Nonetheless, neither BALB/c nor CBA/N mice were protected from lethal pneumococcal infections by immunization with peptide 1-BSA. Preliminary data suggest that peptide 1-BSA is not able to elicit the canonical T15 light chain, explaining the absence of protection. This idiotype-derived mimotope of PC is a useful tool for understanding immunologic cross-reactivity and learning to design T-cell-dependent vaccines for S. pneumoniae.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10992485      PMCID: PMC101537          DOI: 10.1128/IAI.68.10.5778-5784.2000

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  51 in total

Review 1.  Aspects of pneumococcal infection including bacterial virulence, host response and vaccination.

Authors:  S H Gillespie
Journal:  J Med Microbiol       Date:  1989-04       Impact factor: 2.472

2.  Inhibition of self-binding antibodies (autobodies) by a VH-derived peptide.

Authors:  C Y Kang; T K Brunck; T Kieber-Emmons; J E Blalock; H Kohler
Journal:  Science       Date:  1988-05-20       Impact factor: 47.728

3.  The "patchy" immunodeficiency of CBA/N mice.

Authors:  J Quintáns
Journal:  Eur J Immunol       Date:  1977-10       Impact factor: 5.532

4.  The effects of subclass on the ability of anti-phosphocholine antibodies to protect mice from fatal infection with Streptococcus pneumoniae.

Authors:  D E Briles; C Forman; S Hudak; J L Claflin
Journal:  J Mol Cell Immunol       Date:  1984

5.  Antiphosphocholine antibodies found in normal mouse serum are protective against intravenous infection with type 3 streptococcus pneumoniae.

Authors:  D E Briles; M Nahm; K Schroer; J Davie; P Baker; J Kearney; R Barletta
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

6.  Anti-phosphocholine hybridoma antibodies. II. Functional analysis of binding sites within three antibody families.

Authors:  C M Andres; A Maddalena; S Hudak; N M Young; J L Claflin
Journal:  J Exp Med       Date:  1981-11-01       Impact factor: 14.307

7.  Subclass restriction of murine antibodies. III. Antigens that stimulate IgG3 in mice stimulate IgG2c in rats.

Authors:  G P Der Balian; J Slack; B L Clevinger; H Bazin; J M Davie
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

8.  Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.

Authors:  S J Collins; F W Ruscetti; R E Gallagher; R C Gallo
Journal:  Proc Natl Acad Sci U S A       Date:  1978-05       Impact factor: 11.205

9.  Structure of the complex polysaccharide C-substance from Streptococcus pneumoniae type 1.

Authors:  H J Jennings; C Lugowski; N M Young
Journal:  Biochemistry       Date:  1980-09-30       Impact factor: 3.162

10.  Anti-phosphorylcholine antibodies of the T15 idiotype are optimally protective against Streptococcus pneumoniae.

Authors:  D E Briles; C Forman; S Hudak; J L Claflin
Journal:  J Exp Med       Date:  1982-10-01       Impact factor: 14.307

View more
  3 in total

1.  Evaluation of Protective Efficacy of Selected Immunodominant B-Cell Epitopes within Virulent Surface Proteins of Streptococcus pneumoniae.

Authors:  Theodora Papastamatiou; John G Routsias; Olga Koutsoni; Eleni Dotsika; Athanassios Tsakris; Vana Spoulou
Journal:  Infect Immun       Date:  2018-02-20       Impact factor: 3.441

2.  Immunogenicity and efficacy of Cryptococcus neoformans capsular polysaccharide glucuronoxylomannan peptide mimotope-protein conjugates in human immunoglobulin transgenic mice.

Authors:  Robert W Maitta; Kausik Datta; Andrew Lees; Shelley Sims Belouski; Liise-anne Pirofski
Journal:  Infect Immun       Date:  2004-01       Impact factor: 3.441

3.  B cell receptor revision diminishes the autoreactive B cell response after antigen activation in mice.

Authors:  Ying-Hua Wang; Betty Diamond
Journal:  J Clin Invest       Date:  2008-08       Impact factor: 14.808

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.